US Stock MarketDetailed Quotes

Immuneering (IMRX)

Watchlist
  • 6.040
  • -0.090-1.47%
Close Apr 24 15:59 ET
  • 5.930
  • -0.110-1.82%
Post 20:01 ET
390.77MMarket Cap-4.76P/E (TTM)

Immuneering (IMRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.55%-45.34M
32.18%-9.84M
11.10%-11.98M
18.04%-9.45M
9.11%-14.08M
-12.32%-55M
-23.23%-14.51M
-12.02%-13.47M
-7.23%-11.53M
-7.44%-15.49M
Net income from continuing operations
8.21%-56.02M
35.85%-11.58M
-2.52%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
Operating gains losses
-69.15%2.09K
----
----
----
----
72.23%6.78K
122.68%5.47K
----
----
----
Depreciation and amortization
-8.13%353.78K
-10.95%83.21K
-10.50%86.16K
-6.14%91.84K
-5.07%92.58K
9.37%385.07K
-3.75%93.43K
12.45%96.27K
14.37%97.85K
16.32%97.53K
Change In working capital
513.23%3.82M
-95.12%82.57K
306.53%1.36M
353.53%3.29M
66.37%-902.53K
5.05%-925.38K
-10.19%1.69M
17.25%-657.59K
2,577.24%724.49K
-28.38%-2.68M
-Change in receivables
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in prepaid assets
2,078.03%491.84K
-221.86%-1.41M
73.81%-168.82K
223.14%970.53K
342.91%1.1M
85.60%-24.87K
2,862.75%1.16M
21.25%-644.55K
-550.66%-788.13K
-51.47%248.9K
-Change in payables and accrued expense
898.29%2.5M
143.43%1.06M
791.04%1.39M
34.51%2.34M
13.18%-2.3M
18.69%-312.97K
-79.35%437.05K
117.96%156.22K
3,644.43%1.74M
-4.79%-2.65M
-Change in other current assets
526.36%1.11M
--311.4K
615.25%348.79K
57.59%-94.84K
1,729.67%548.9K
10.11%-261.34K
--0
---67.69K
---223.64K
--30K
-Change in other current liabilities
13.99%-280.58K
24.71%119.52K
-110.54%-213.85K
2,795.18%71.02K
19.06%-257.27K
-135.11%-326.21K
-3.75%95.84K
-112.21%-101.57K
97.36%-2.64K
-250.60%-317.84K
Cash from discontinued investing activities
Operating cash flow
17.55%-45.34M
32.18%-9.84M
11.10%-11.98M
18.04%-9.45M
9.11%-14.08M
-12.32%-55M
-23.23%-14.51M
-12.02%-13.47M
-7.23%-11.53M
-7.44%-15.49M
Investing cash flow
Cash flow from continuing investing activities
-435.69%-88.74M
-1,715.84%-88.72M
99.87%-7.26K
-100.04%-2.12K
-100.04%-8.95K
262.30%26.43M
75.26%5.49M
77.41%-5.42M
-45.79%4.97M
12.76%21.39M
Net PPE purchase and sale
-67.57%-142.23K
-1,224.39%-123.91K
-37.72%-7.26K
93.54%-2.12K
76.13%-8.95K
75.24%-84.88K
94.53%-9.36K
90.78%-5.27K
62.19%-32.77K
-33.88%-37.48K
Net investment purchase and sale
-434.07%-88.6M
-1,710.84%-88.6M
--0
--0
--0
247.15%26.52M
66.47%5.5M
77.38%-5.41M
-45.95%5M
12.79%21.43M
Cash from discontinued investing activities
Investing cash flow
-435.69%-88.74M
-1,715.84%-88.72M
99.87%-7.26K
-100.04%-2.12K
-100.04%-8.95K
262.30%26.43M
75.26%5.49M
77.41%-5.42M
-45.79%4.97M
12.76%21.39M
Financing cash flow
Cash flow from continuing financing activities
4,172.32%226.58M
-772.26%-357.52K
4,784.59%213.19M
-61.96K
1,309.35%13.81M
-81.35%5.3M
-623.14%-40.99K
20,249.61%4.36M
0
309.31%979.92K
Net common stock issuance
5,316.51%229.52M
--0
4,993.75%215.84M
--0
--13.68M
-84.97%4.24M
--0
--4.24M
--0
--0
Proceeds from stock option exercised by employees
-28.60%790.44K
--229.83K
233.89%424.66K
--2.06K
-86.34%133.89K
148.88%1.11M
--0
493.00%127.19K
--0
309.31%979.92K
Net other financing activities
-8,991.11%-3.73M
---587.36K
---3.07M
----
----
79.88%-40.99K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
4,172.32%226.58M
-772.26%-357.52K
4,784.59%213.19M
---61.96K
1,309.35%13.81M
-81.35%5.3M
-623.14%-40.99K
20,249.61%4.36M
--0
309.31%979.92K
Net cash flow
Beginning cash position
-39.16%36.14M
403.40%227.56M
-55.87%26.36M
-45.89%35.87M
-39.16%36.14M
-18.22%59.41M
-33.56%45.21M
-42.58%59.73M
-14.39%66.29M
-18.22%59.41M
Current changes in cash
497.66%92.5M
-991.71%-98.92M
1,485.45%201.21M
-45.00%-9.51M
-104.05%-279.02K
-75.81%-23.26M
-4.94%-9.06M
59.63%-14.52M
-124.67%-6.56M
43.56%6.88M
End cash Position
255.92%128.65M
255.92%128.65M
403.40%227.56M
-55.87%26.36M
-45.89%35.87M
-39.16%36.14M
-39.16%36.14M
-33.56%45.21M
-42.58%59.73M
-14.39%66.29M
Free cash flow
17.42%-45.49M
31.37%-9.96M
11.08%-11.98M
18.26%-9.45M
9.27%-14.09M
-11.71%-55.08M
-21.54%-14.52M
-11.53%-13.48M
-6.68%-11.56M
-7.49%-15.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.55%-45.34M32.18%-9.84M11.10%-11.98M18.04%-9.45M9.11%-14.08M-12.32%-55M-23.23%-14.51M-12.02%-13.47M-7.23%-11.53M-7.44%-15.49M
Net income from continuing operations 8.21%-56.02M35.85%-11.58M-2.52%-14.96M-2.51%-14.43M-5.16%-15.05M-14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M
Operating gains losses -69.15%2.09K----------------72.23%6.78K122.68%5.47K------------
Depreciation and amortization -8.13%353.78K-10.95%83.21K-10.50%86.16K-6.14%91.84K-5.07%92.58K9.37%385.07K-3.75%93.43K12.45%96.27K14.37%97.85K16.32%97.53K
Change In working capital 513.23%3.82M-95.12%82.57K306.53%1.36M353.53%3.29M66.37%-902.53K5.05%-925.38K-10.19%1.69M17.25%-657.59K2,577.24%724.49K-28.38%-2.68M
-Change in receivables ----------------------0--0--0--0--0
-Change in prepaid assets 2,078.03%491.84K-221.86%-1.41M73.81%-168.82K223.14%970.53K342.91%1.1M85.60%-24.87K2,862.75%1.16M21.25%-644.55K-550.66%-788.13K-51.47%248.9K
-Change in payables and accrued expense 898.29%2.5M143.43%1.06M791.04%1.39M34.51%2.34M13.18%-2.3M18.69%-312.97K-79.35%437.05K117.96%156.22K3,644.43%1.74M-4.79%-2.65M
-Change in other current assets 526.36%1.11M--311.4K615.25%348.79K57.59%-94.84K1,729.67%548.9K10.11%-261.34K--0---67.69K---223.64K--30K
-Change in other current liabilities 13.99%-280.58K24.71%119.52K-110.54%-213.85K2,795.18%71.02K19.06%-257.27K-135.11%-326.21K-3.75%95.84K-112.21%-101.57K97.36%-2.64K-250.60%-317.84K
Cash from discontinued investing activities
Operating cash flow 17.55%-45.34M32.18%-9.84M11.10%-11.98M18.04%-9.45M9.11%-14.08M-12.32%-55M-23.23%-14.51M-12.02%-13.47M-7.23%-11.53M-7.44%-15.49M
Investing cash flow
Cash flow from continuing investing activities -435.69%-88.74M-1,715.84%-88.72M99.87%-7.26K-100.04%-2.12K-100.04%-8.95K262.30%26.43M75.26%5.49M77.41%-5.42M-45.79%4.97M12.76%21.39M
Net PPE purchase and sale -67.57%-142.23K-1,224.39%-123.91K-37.72%-7.26K93.54%-2.12K76.13%-8.95K75.24%-84.88K94.53%-9.36K90.78%-5.27K62.19%-32.77K-33.88%-37.48K
Net investment purchase and sale -434.07%-88.6M-1,710.84%-88.6M--0--0--0247.15%26.52M66.47%5.5M77.38%-5.41M-45.95%5M12.79%21.43M
Cash from discontinued investing activities
Investing cash flow -435.69%-88.74M-1,715.84%-88.72M99.87%-7.26K-100.04%-2.12K-100.04%-8.95K262.30%26.43M75.26%5.49M77.41%-5.42M-45.79%4.97M12.76%21.39M
Financing cash flow
Cash flow from continuing financing activities 4,172.32%226.58M-772.26%-357.52K4,784.59%213.19M-61.96K1,309.35%13.81M-81.35%5.3M-623.14%-40.99K20,249.61%4.36M0309.31%979.92K
Net common stock issuance 5,316.51%229.52M--04,993.75%215.84M--0--13.68M-84.97%4.24M--0--4.24M--0--0
Proceeds from stock option exercised by employees -28.60%790.44K--229.83K233.89%424.66K--2.06K-86.34%133.89K148.88%1.11M--0493.00%127.19K--0309.31%979.92K
Net other financing activities -8,991.11%-3.73M---587.36K---3.07M--------79.88%-40.99K----------------
Cash from discontinued financing activities
Financing cash flow 4,172.32%226.58M-772.26%-357.52K4,784.59%213.19M---61.96K1,309.35%13.81M-81.35%5.3M-623.14%-40.99K20,249.61%4.36M--0309.31%979.92K
Net cash flow
Beginning cash position -39.16%36.14M403.40%227.56M-55.87%26.36M-45.89%35.87M-39.16%36.14M-18.22%59.41M-33.56%45.21M-42.58%59.73M-14.39%66.29M-18.22%59.41M
Current changes in cash 497.66%92.5M-991.71%-98.92M1,485.45%201.21M-45.00%-9.51M-104.05%-279.02K-75.81%-23.26M-4.94%-9.06M59.63%-14.52M-124.67%-6.56M43.56%6.88M
End cash Position 255.92%128.65M255.92%128.65M403.40%227.56M-55.87%26.36M-45.89%35.87M-39.16%36.14M-39.16%36.14M-33.56%45.21M-42.58%59.73M-14.39%66.29M
Free cash flow 17.42%-45.49M31.37%-9.96M11.08%-11.98M18.26%-9.45M9.27%-14.09M-11.71%-55.08M-21.54%-14.52M-11.53%-13.48M-6.68%-11.56M-7.49%-15.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More